223 related articles for article (PubMed ID: 24675874)
1. Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH.
Chabot PR; Raiola L; Lussier-Price M; Morse T; Arseneault G; Archambault J; Omichinski JG
PLoS Pathog; 2014 Mar; 10(3):e1004042. PubMed ID: 24675874
[TBL] [Abstract][Full Text] [Related]
2. NMR structure of the complex between the Tfb1 subunit of TFIIH and the activation domain of VP16: structural similarities between VP16 and p53.
Langlois C; Mas C; Di Lello P; Jenkins LM; Legault P; Omichinski JG
J Am Chem Soc; 2008 Aug; 130(32):10596-604. PubMed ID: 18630911
[TBL] [Abstract][Full Text] [Related]
3. Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53.
Di Lello P; Jenkins LMM; Jones TN; Nguyen BD; Hara T; Yamaguchi H; Dikeakos JD; Appella E; Legault P; Omichinski JG
Mol Cell; 2006 Jun; 22(6):731-740. PubMed ID: 16793543
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
Wang L; Grossman SR; Kieff E
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
[TBL] [Abstract][Full Text] [Related]
5. NMR structure of the amino-terminal domain from the Tfb1 subunit of TFIIH and characterization of its phosphoinositide and VP16 binding sites.
Di Lello P; Nguyen BD; Jones TN; Potempa K; Kobor MS; Legault P; Omichinski JG
Biochemistry; 2005 May; 44(21):7678-86. PubMed ID: 15909982
[TBL] [Abstract][Full Text] [Related]
6. Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
Ponnusamy R; Khatri R; Correia PB; Wood CD; Mancini EJ; Farrell PJ; West MJ
PLoS Pathog; 2019 Jul; 15(7):e1007458. PubMed ID: 31283782
[TBL] [Abstract][Full Text] [Related]
7. BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.
Harter MR; Liu CD; Shen CL; Gonzalez-Hurtado E; Zhang ZM; Xu M; Martinez E; Peng CW; Song J
PLoS Pathog; 2016 Feb; 12(2):e1005414. PubMed ID: 26845565
[TBL] [Abstract][Full Text] [Related]
8. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
[TBL] [Abstract][Full Text] [Related]
9. p53 and TFIIEalpha share a common binding site on the Tfb1/p62 subunit of TFIIH.
Di Lello P; Miller Jenkins LM; Mas C; Langlois C; Malitskaya E; Fradet-Turcotte A; Archambault J; Legault P; Omichinski JG
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):106-11. PubMed ID: 18160537
[TBL] [Abstract][Full Text] [Related]
10. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
[TBL] [Abstract][Full Text] [Related]
11. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional evidence that Rad4 competes with Rad2 for binding to the Tfb1 subunit of TFIIH in NER.
Lafrance-Vanasse J; Arseneault G; Cappadocia L; Legault P; Omichinski JG
Nucleic Acids Res; 2013 Feb; 41(4):2736-45. PubMed ID: 23295669
[TBL] [Abstract][Full Text] [Related]
14. EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.
Beer S; Wange LE; Zhang X; Kuklik-Roos C; Enard W; Hammerschmidt W; Scialdone A; Kempkes B
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2200512119. PubMed ID: 35857872
[TBL] [Abstract][Full Text] [Related]
15. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
Su C; Lu F; Soldan SS; Lamontagne RJ; Tang HY; Napoletani G; Farrell PJ; Tempera I; Kossenkov AV; Lieberman PM
PLoS Pathog; 2021 Aug; 17(8):e1009834. PubMed ID: 34352044
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of interactions involving the Tfb1 subunit of TFIIH and the NER factor Rad2.
Lafrance-Vanasse J; Arseneault G; Cappadocia L; Chen HT; Legault P; Omichinski JG
Nucleic Acids Res; 2012 Jul; 40(12):5739-50. PubMed ID: 22373916
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF).
Mas C; Lussier-Price M; Soni S; Morse T; Arseneault G; Di Lello P; Lafrance-Vanasse J; Bieker JJ; Omichinski JG
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10484-9. PubMed ID: 21670263
[TBL] [Abstract][Full Text] [Related]
18. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
Peng R; Tan J; Ling PD
J Virol; 2000 Nov; 74(21):9953-63. PubMed ID: 11024123
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of interactions between transactivation domain 1 of the p65 subunit of NF-κB and transcription regulatory factors.
Lecoq L; Raiola L; Chabot PR; Cyr N; Arseneault G; Legault P; Omichinski JG
Nucleic Acids Res; 2017 May; 45(9):5564-5576. PubMed ID: 28334776
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.
Zhao B; Zou J; Wang H; Johannsen E; Peng CW; Quackenbush J; Mar JC; Morton CC; Freedman ML; Blacklow SC; Aster JC; Bernstein BE; Kieff E
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14902-7. PubMed ID: 21746931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]